Immunology and Biotherapies
42.4K views | +21 today
Follow
Immunology and Biotherapies
Page Ressources et Actualités du DIU immunologie et biothérapies
Your new post is loading...
Your new post is loading...
Scooped by Gilbert C FAURE
July 25, 2012 11:13 AM
Scoop.it!

Serum IgG responses against Asp... [Biol Blood Marrow Transplant. 2012] - PubMed - NCBI

PubMed comprises more than 21 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.
No comment yet.
Scooped by Gilbert C FAURE
July 25, 2012 9:00 AM
Scoop.it!

Oncology News - Reduced intensity allogeneic hematopoietic stem cell transplantation for MDS using tacrolimus/sirolimus-based GVHD prophylaxis |4144529

Oncology Medical Article: Reduced intensity allogeneic hematopoietic stem cell transplantation for MDS using tacrolimus/sirolimus-based GVHD prophylaxis (Reduced intensity allogeneic hematopoietic stem cell transplantation for MDS using tacrolimus...)...
No comment yet.
Scooped by Gilbert C FAURE
July 25, 2012 4:55 AM
Scoop.it!

Effect of a monoclonal antibody to PCSK9, REGN727/SAR... [Lancet. 2012] - PubMed - NCBI

PubMed comprises more than 21 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.
No comment yet.
Scooped by Gilbert C FAURE
July 25, 2012 3:49 AM
Scoop.it!

New guidelines urge immediate treatment after HIV infection - Harvard Health Publications

New guidelines urge immediate treatment after HIV infection - Harvard Health Publications | Immunology and Biotherapies | Scoop.it
New guidelines now urge adults who have been infected with HIV to start taking HIV-fighting drugs as soon as possible, ideally within two weeks of being diagnosed with the infection, rather than waiting to see what happens with white blood cell...
No comment yet.
Scooped by Gilbert C FAURE
July 25, 2012 3:48 AM
Scoop.it!

Pluristem Focuses On Therapeutic Cells Delivered Intramuscularly ...

20000000. This is the number of peripheral artery disease patients Pluristem Therapeutics, a placenta-based cell therapy company, is working to assist. The company recently released information regarding the effectiveness of cell therapy ...
No comment yet.
Scooped by Gilbert C FAURE
July 24, 2012 1:23 PM
Scoop.it!

Bevacizumab With or Without Anti-Endoglin Monoclonal Antibody TRC105 in Treating Patients With Recurrent Glioblastoma Multiforme - Full Text View - ClinicalTrials.gov

Bevacizumab With or Without Anti-Endoglin Monoclonal Antibody TRC105 in Treating Patients With Recur http://t.co/KEVBD7kb...
No comment yet.
Scooped by Gilbert C FAURE
July 24, 2012 11:28 AM
Scoop.it!

Free Article: Intraspinal Stem Cell Transplantation - Blogs

Free Article: Intraspinal Stem Cell Transplantation - Blogs | Immunology and Biotherapies | Scoop.it
Free Article: Intraspinal Stem Cell Transplantation. leave a comment ». Background: No United States-based clinical trials have attempted delivery of biological therapies directly to the spinal cord for treatment of amyotrophic ...
No comment yet.
Scooped by Gilbert C FAURE
July 24, 2012 7:14 AM
Scoop.it!

DGAP-News: SuppreMol GmbH: SuppreMol begins development of Anti-IL-3 monoclonal antibody to diagnose and treat early stage Rheumatoid Arthritis

DGAP-News: SuppreMol GmbH / Key word(s): StudySuppreMol GmbH: SuppreMol begins development of Anti-IL-3 monoclonalantibody to diagnose and treat early stage Rheumatoid Arthritis24.07.2012 /...
No comment yet.
Scooped by Gilbert C FAURE
July 23, 2012 1:44 PM
Scoop.it!

Antibody therapy may stabilize early Alzheimer’s symptoms > Facts & Fears > ACSH

Antibody therapy may stabilize early Alzheimer’s symptoms > Facts & Fears > ACSH via @rosie_ms: Antibody therapy may...
No comment yet.
Scooped by Gilbert C FAURE
July 23, 2012 7:19 AM
Scoop.it!

CYDY - Promising Antibody Technology for the Treatment of HIV/FIV

CYDY - Promising Antibody Technology for the Treatment of HIV/FIV | Immunology and Biotherapies | Scoop.it
CytoDyn (Other OTC:CYDY.PK - News) is a development stage biotech company focused on the discovery and development of novel anti-HIV and anti-FIV agents. The Company holds two proprietary platform technologies: Cytolin, a ...
No comment yet.
Scooped by Gilbert C FAURE
July 20, 2012 3:37 PM
Scoop.it!

Biotest’s Antibody-drug Conjugate BT-062 In Multiple Myeloma Combination Therapy

Biotest’s Antibody-drug Conjugate BT-062 In Multiple Myeloma Combination Therapy | Immunology and Biotherapies | Scoop.it
Biotest’s Antibody-drug Conjugate BT-062 In Multiple Myeloma Combination Therapy (#clinicaltrials Biotest’s Antibody-drug Conjugate BT-062 In Multiple Myeloma Combination Therapy: BT-062, an ant...)...
No comment yet.
Scooped by Gilbert C FAURE
July 20, 2012 3:35 PM
Scoop.it!

Free Article: Intraspinal Stem Cell Transplantation

Free Article: Intraspinal Stem Cell Transplantation | Immunology and Biotherapies | Scoop.it
Background: No United States-based clinical trials have attempted delivery of biological therapies directly to the spinal cord for treatment of amyotrophic lateral sclerosis (ALS) because of the lack of a meaningful US Food and Drug...
No comment yet.
Scooped by Gilbert C FAURE
July 20, 2012 3:30 PM
Scoop.it!

Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy - Full Text View - ClinicalTrials.gov

Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Prev...
No comment yet.
Scooped by Gilbert C FAURE
July 25, 2012 9:05 AM
Scoop.it!

Sweat glands grown from newly identified stem cells

Sweat glands grown from newly identified stem cells | Immunology and Biotherapies | Scoop.it
To date, few fundamentals have been known about the most common gland in the body, the sweat glands that are essential to controlling body temperature, allowing humans to live in the world’s diverse climates.
No comment yet.
Scooped by Gilbert C FAURE
July 25, 2012 8:59 AM
Scoop.it!

Symposier - Nimotuzumab: Proposed Mechanism of Action

Symposier - Nimotuzumab: Proposed Mechanism of Action | Immunology and Biotherapies | Scoop.it
Uploaded and shared in Youtube by: ymbiosciences —Nimotuzumab is a humanized monoclonal antibody that targets and binds to the epidermal growth factor receptor (EGFR).
No comment yet.
Scooped by Gilbert C FAURE
July 25, 2012 4:54 AM
Scoop.it!

World’s leading transplantation experts lock in Melbourne for 2015 | Invest Victoria Blog

World’s leading transplantation experts lock in Melbourne for 2015 | Invest Victoria Blog | Immunology and Biotherapies | Scoop.it
World’s leading transplantation experts lock in #Melbourne for 2015 http://t.co/rbxT9b3W...
No comment yet.
Scooped by Gilbert C FAURE
July 25, 2012 3:49 AM
Scoop.it!

Researchers discover new target for vaccine development in abundant immune ... - Medical Xpress

Researchers discover new target for vaccine development in abundant immune ... - Medical Xpress | Immunology and Biotherapies | Scoop.it
Researchers discover new target for vaccine development in abundant immune ...Medical XpressResearchers evaluated healthy human tissues key to the immune system to assess the abundance of neutrophils in the lymph nodes, tonsils, lymphoid tissue in...
No comment yet.
Scooped by Gilbert C FAURE
July 24, 2012 1:24 PM
Scoop.it!

Chemotherapy, Imatinib Mesylate, and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia - Full Text View - ClinicalTrials.gov

Chemotherapy, Imatinib Mesylate, and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagno...
No comment yet.
Rescooped by Gilbert C FAURE from Immune-Monitoring
July 24, 2012 1:21 PM
Scoop.it!

Tumor progression-related transmembrane protein aspartate-{Beta}-hydroxylase is a target for immunotherapy of hepatocellular carcinoma.

antigenic target


Via Marcelo de Carvalho Bittencourt
No comment yet.
Scooped by Gilbert C FAURE
July 24, 2012 7:15 AM
Scoop.it!

Aegis Awarded Patent for Monoclonal Antibody Formulations That Avoid Oxidative Damage Due to Polysorbate Surfactants

SAN DIEGO, CA -- (Marketwire) -- 07/24/12 -- Aegis Therapeutics LLC announced today that it has been awarded U.S. Patent No. 8,226,949 providing broad protection for stabilized formulations of monoclonal antibodies.
No comment yet.
Scooped by Gilbert C FAURE
July 24, 2012 4:24 AM
Scoop.it!

New stem cell therapy succesfully rejuvenates aging heart muscle cells in humans

New stem cell therapy succesfully rejuvenates aging heart muscle cells in humans | Immunology and Biotherapies | Scoop.it
Damaged and aged heart tissue of older heart failure patients was rejuvenated by stem cells modified by scientists, according to research presented at the Ameri (RT @AGE: New stem cell therapy succesfully rejuvenates aging heart muscle cells in humans.)...
No comment yet.
Scooped by Gilbert C FAURE
July 23, 2012 1:43 PM
Scoop.it!

A Phase I Trial Of The Humanized Anti-GD2 Antibody In Children And Adolescents With Neuroblastoma, Osteosarcoma Or Melanoma | Clinical Trials News Digest

A Phase I Trial Of The Humanized Anti-GD2 Antibody In Children And Adolescents With Neuroblastoma, Osteosarcoma Or Melanoma | Clinical Trials News Digest | Immunology and Biotherapies | Scoop.it
Conditions :   Neuroblastoma;   Melanoma;   Osteosarcoma Intervention :   Biological: Anti-G2 antibody Sponsors :   St. Jude Children's Research Hospital;   St. Jude Children's Research Hospital;   Evan T. J. Dunbar Neuroblastoma Foundation, Inc.;...
No comment yet.
Scooped by Gilbert C FAURE
July 21, 2012 11:08 AM
Scoop.it!

Tips for Translational Cell Therapy Research [audio] | Eureka

Tips for Translational Cell Therapy Research [audio] | Eureka | Immunology and Biotherapies | Scoop.it
In this Eureka Podcast Episode, Shawna Jackman, Senior Research Scientist at Charles River, provides her top 10 tips to consider when designing a translational cell therapy preclinical program.
No comment yet.
Scooped by Gilbert C FAURE
July 20, 2012 3:36 PM
Scoop.it!

Sanofi and Regeneron Launch Comprehensive Phase 3 Clinical Program With LDL Cholesterol-Lowering PCSK9 Antibody - Drugs.com MedNews

Sanofi and Regeneron Launch Comprehensive Phase 3 Clinical Program With LDL Cholesterol-Lowering PCSK9 Antibody - Drugs.com MedNews | Immunology and Biotherapies | Scoop.it
ODYSSEY, a global program to evaluate SAR236553 REGN727, a potential first-in-class PCSK9 inhibitor, will comprise over ten clinical trials and will include mor (Sanofi and Regeneron Launch Comprehensive Phase 3 Clinical Program With LDL Cholesterol-Lowering...
No comment yet.
Scooped by Gilbert C FAURE
July 20, 2012 3:30 PM
Scoop.it!

Decitabine as Maintenance Therapy After Standard Therapy in Treating Patients With Previously Untreated Acute Myeloid Leukemia - Full Text View - ClinicalTrials.gov

Decitabine as Maintenance Therapy After Standard Therapy in Treating Patients With Previously Untreated Acute My...
No comment yet.